We are live on ! Find out more
RPRX icon

Royalty Pharma
RPRX

378 hedge funds and large institutions have $8.35B invested in Royalty Pharma in 2024 Q2 according to their latest regulatory filings, with 60 funds opening new positions, 141 increasing their positions, 127 reducing their positions, and 56 closing their positions.

New
Increased
Maintained
Reduced
Closed

222% more call options, than puts

Call options by funds: $13.5M | Put options by funds: $4.19M

11% more repeat investments, than reductions

Existing positions increased: 141 | Existing positions reduced: 127

1.94% more ownership

Funds ownership: 68.15% → 70.09% (+1.9%)

7% more first-time investments, than exits

New positions opened: 60 | Existing positions closed: 56

0% more funds holding

Funds holding: 378 → 378 (0)

0% more funds holding in top 10

Funds holding in top 10: 7 → 7 (0)

10% less capital invested

Capital invested by funds: $9.24B → $8.35B (-$885M)

Holders
378
Holders Change
–
Holders Change %
0%
% of All Funds
5.46%
Holding in Top 10
7
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.1%
New
60
Increased
141
Reduced
127
Closed
56
Calls
$13.5M
Puts
$4.19M
Net Calls
+$9.31M
Net Calls Change
+$4.69M

Top Buyers

1
Swedbank
Swedbank
Sweden
+$300M
2
BlackRock
BlackRock
New York
+$50.2M
3
BGIM
Brandywine Global Investment Management
Pennsylvania
+$45.4M
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$29.5M
5
Invesco
Invesco
Georgia
+$29.5M

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$159M
2
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance)
Ontario, Canada
-$81.4M
3
Millennium Management
Millennium Management
New York
-$64.2M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
-$15.8M
5
CSS
Cubist Systematic Strategies
Connecticut
-$14.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
First Trust Advisors
51
First Trust Advisors
Illinois
$23.8M +$24.4M +879,632 +3,546%
Russell Investments Group
52
Russell Investments Group
United Kingdom
$21.6M +$11.6M +416,816 +104%
Dimensional Fund Advisors
53
Dimensional Fund Advisors
Texas
$20.8M +$3.87M +139,761 +22%
AQR Capital Management
54
AQR Capital Management
Connecticut
$20.7M +$8.89M +320,606 +69%
Canada Pension Plan Investment Board
55
Canada Pension Plan Investment Board
Ontario, Canada
$20.7M -$3.86M -139,074 -15%
EAM
56
Eventide Asset Management
Massachusetts
$19.8M +$1.63M +58,943 +9%
MAMU
57
Marathon Asset Management (UK)
United Kingdom
$19.6M -$1.35M -48,680 -6%
RJA
58
Raymond James & Associates
Florida
$19.3M -$1.41M -50,871 -6%
DekaBank Deutsche Girozentrale
59
DekaBank Deutsche Girozentrale
Germany
$19.3M -$560K -20,216 -3%
California State Teachers Retirement System (CalSTRS)
60
California State Teachers Retirement System (CalSTRS)
California
$19.3M +$2.28M +82,385 +13%
Handelsbanken Fonder
61
Handelsbanken Fonder
Sweden
$18.9M +$935K +33,728 +5%
Alyeska Investment Group
62
Alyeska Investment Group
Illinois
$18.8M -$12.1M -437,367 -38%
TIP
63
Torray Investment Partners
Maryland
$18.3M +$651K +23,498 +4%
CCM
64
Cutter Capital Management
New York
$18.3M +$7.78M +280,760 +68%
Victory Capital Management
65
Victory Capital Management
Texas
$17.7M +$5.85M +211,131 +46%
APG Asset Management
66
APG Asset Management
Netherlands
$17M +$8.29M +298,986 +76%
Citigroup
67
Citigroup
New York
$15.7M +$3.41M +122,896 +26%
Schroder Investment Management Group
68
Schroder Investment Management Group
United Kingdom
$14.5M -$137K -4,938 -0.9%
RPAM
69
Rhenman & Partners Asset Management
Sweden
$14.4M – – –
HSBC Holdings
70
HSBC Holdings
United Kingdom
$13.8M -$11.1M -399,619 -43%
SAM
71
Storebrand Asset Management
Norway
$12M +$643K +23,213 +5%
RhumbLine Advisers
72
RhumbLine Advisers
Massachusetts
$11.8M -$309K -11,165 -2%
Los Angeles Capital Management
73
Los Angeles Capital Management
California
$11.7M -$7.16M -258,371 -37%
RRAM
74
River Road Asset Management
Kentucky
$11.3M -$397K -14,318 -3%
PAIM
75
Punch & Associates Investment Management
Minnesota
$11.2M +$1.54M +55,625 +15%
1 2
3
4 5

RPRX Hedge Fund Activity: Q2 2024 in Review

378 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Royalty Pharma (RPRX) for Q2 2024, worth a combined $8.35B — down 9.6% from $9.24B a quarter earlier.

Buyers outnumbered sellers: 60 funds opened new RPRX positions and 56 closed out — a net gain of 4 holders — while 141 added to existing stakes and 127 trimmed.

The largest buyer was Swedbank, opening a new position worth an estimated $300M. The largest seller was Fidelity Investments, cutting an estimated $159M.

  • 378 institutional investors held Royalty Pharma (RPRX) as of Q2 2024, unchanged from Q1 2024.
  • Funds reported $8.35B of Royalty Pharma stock for Q2 2024, down 9.6% quarter-over-quarter.
  • 60 funds opened new Royalty Pharma positions in Q2 2024 and 56 closed out, a net change of +4 holders.
  • The largest Royalty Pharma buyer in Q2 2024 was Swedbank, an estimated $300M added.
  • The largest Royalty Pharma seller in Q2 2024 was Fidelity Investments, an estimated $159M sold.

Based on aggregated 13F filings for Q2 2024.